Chair, Sara Hurvitz, MD, William J. Gradishar, MD, FASCO, FACP, and Sara M. Tolaney, MD, MPH, discuss metastatic HER2-positive breast cancer in this CME/MOC/NCPD activity titled “Making Progress in Early and Advanced HER2-Positive Breast Cancer: Leveraging HER2-Targeted Therapies and Modern Care Principles to Improve Clinical Outcomes and Health Equity.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD information, and to apply for credit, please visit us at PeerView.com/SAA865. CME/MOC/NCPD credit will be available until July 1, 2022.
